Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,245,201
+$819,913 QoQ
Shares Held
24,818
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
#1,178
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kendall Capital Management holds $22,925,368 across 11 Drug Manufacturers - General names. ABBV ranks #1 (27.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
24,818 | $6,245,201 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
69,150 | $3,984,423 | |
| 3 | GSK |
GSK plc
|
50,941 | $2,670,327 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,682 | $2,529,137 | |
| 5 | JNJ |
Johnson & Johnson
|
8,136 | $2,066,299 | |
| 6 | PFE |
Pfizer Inc
|
49,545 | $1,193,043 | |
| 7 | AMGN |
Amgen Inc
|
2,995 | $1,084,549 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,362 | $1,056,455 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,245,201 | 24,818 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,425,288 | 24,945 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $5,693,513 | 24,918 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $6,076,072 | 26,242 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,005,057 | 26,964 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $5,780,656 | 27,590 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $5,357,121 | 30,147 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $6,329,628 | 32,052 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,613,335 | 32,727 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,982,531 | 32,853 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,186,535 | 33,468 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $4,834,761 | 32,435 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $4,343,695 | 32,240 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $5,021,589 | 31,509 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,036,090 | 31,162 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $4,309,348 | 32,109 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $4,974,483 | 32,479 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $5,402,153 | 33,324 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,757,820 | 35,139 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $3,876,308 | 35,935 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $4,152,473 | 36,865 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,058,250 | 37,500 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $3,984,908 | 37,190 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,286,814 | 37,525 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $3,598,787 | 36,655 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $2,520,365 | 33,080 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||